1. Binenbaum, Z., Parola, A. H., Zaritzky, A., and Fishov, I., Transcription- and translation-dependent changes in membrane dynamics in bacteria: testing the transertion model for domain formation.Mol. Microbiol., 32, 1173–1182 (1999).
2. Choppin, J. and Desplaces, A., The action of silybin on the mouse liver in alpha-amanitine poisoning.Arzneim. Forsch., 29, 63–68 (1979).
3. Lecomppte, J., Proprietes pharmacologiques generates de la silybine et de la silymarine chez le rat.Arch. Intl. Pharmacodyn. Ther., 214, 165–176 (1975).
4. Lee, D. G., Park, J. H., Shin, S. Y., Lee, S. G., Lee, M. K., Kim, K. L., and Hahm, K. S., Design of novel analogue peptides with potent fungicidal but low hemolytic activity based on the cecropin A-melittin hybrid structure.Biochem. Mol. Biol. Int., 43, 489–498 (1997).
5. Letteron, P., Labbe, G., Degott, C., Berson, A., Fromenty, B., Delaforge, M., Larrey, D., and Pessayre, D., Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice; Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant.Biochem. Pharmacol., 39, 2027–2034 (1990).